Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAL vs MAL Daylight-PDT for Actinic Keratoses
NCT02149342Phase 2Completed
- Sponsor
- Päijät-Häme Wellbeing Services County
- Start
- May 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hexaminolevulinate in actinic keratosis (AK), sponsored by Päijät-Häme Wellbeing Services County. Started May 2014; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02149342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02149342.